The rationale behind a vaccine based on multiple HIV antigens

Microbes and Infection

Volumn 7, Issue 14, 2005, Pages 1414-1423

  Rollman, E ^a,b   Brave A ^a,b   Boberg, A ^a,b   Gudmundsdotter, L ^a,b   Engstrom G ^a,b   Isaguliants, M ^a,b   Ljungberg, K ^c   Lundgren, B ^d   Blomberg, P ^e   Hinkula, J ^a,b   Hejdeman, B ^e   Sandstrom E ^e   Liu, M ^b,f   Wahren, B ^a,b  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d Visionar Biomedical AB   (Sweden)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^f TRANSGENE S A   (France)

Author keywords

Clinical trials; DNA vaccine; HIV 1

Indexed keywords

DNA VACCINE; ENVELOPE PROTEIN; GAG PROTEIN; GAMMA INTERFERON; GLYCOPROTEIN GP 160; HLA ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOGLOBULIN G; NEF PROTEIN; PLASMID DNA; RECOMBINANT DNA; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; REV PROTEIN; TRANSACTIVATOR PROTEIN; VIRUS ENZYME;

ANTIBODY PRODUCTION; ANTIGENICITY; CATALYSIS; CELLULAR IMMUNITY; CLINICAL TRIAL; CROSS REACTION; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG STABILITY; ENZYME INHIBITION; GENE EXPRESSION; GENE GUN; GENE SEQUENCE; GENETIC VARIABILITY; GOOD MANUFACTURING PRACTICE; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; MOLECULAR CLONING; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SITE DIRECTED MUTAGENESIS; TH1 CELL; WESTERN BLOTTING;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MURINE LEUKEMIA VIRUS;

EID: 27844509119     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2005.07.017     Document Type: Short Survey

References (43)

1. M. Murphey-Corb, L.N. Martin, B. Davison-Fairburn, R.C. Montelaro, M. Miller, M. West, S. Ohkawa, G.B. Baskin, J.Y. Zhang, S.D. Putney, A.C. Allison, and D.A. Eppstein A formalin-inactivated whole SIV vaccine confers protection in macaques Science 246 1989 1293 1297
2. E.J. Stott Anti-cell antibody in macaques Nature 353 1991 393
3. P.W. Berman, J.E. Groopman, T. Gregory, P.R. Clapham, R.A. Weiss, R. Ferriani, L. Riddle, C. Shimasaki, C. Lucas, L.A. Lasky, and J.W. Eichberg Human immunodeficiency virus type 1 challenge of chimpanzees immunized with recombinant envelope glycoprotein gp120 Proc. Natl. Acad. Sci. USA. 85 1988 5200 5204
4. J.E. Hansen, H. Clausen, C. Nielsen, E. Dabelsteen, L. Mathiesen, S.I. Hakomori, and J.O. Nielsen Inhibition of human immunodeficiency virus (HIV) infection in vitro by anticarbohydrate monoclonal antibodies: peripheral glycosylation of HIV envelope glycoprotein gp120 may be a target for virus neutralization J. Virol 64 1990 2833 2840
5. D.P. Francis, W.L. Heyward, V. Popovic, P. Orozco-Cronin, K. Orelind, C. Gee, A. Hirsch, T. Ippolito, A. Luck, M. Longhi, V. Gulati, N. Winslow, M. Gurwith, F. Sinangil, and P.W. Berman Candidate HIV/AIDS vaccines: lessons learned from the World's first phase III efficacy trials AIDS 17 2003 147 156
6. A. Cafaro, A. Caputo, C. Fracasso, M.T. Maggiorella, D. Goletti, S. Baroncelli, M. Pace, L. Sernicola, M.L. Koanga-Mogtomo, M. Betti, A. Borsetti, R. Belli, L. Åkerblom, F. Corrias, S. Buttò, J. Heeney, P. Verani, F. Titti, and B. Ensoli Control of SHIV89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine Nat. Med. 5 1999 643 650
7. G. Voss, K. Manson, D. Montefiori, D.I. Watkins, J. Heeney, M. Wyand, J. Cohen, and C. Bruck Prevention of disease induced by a partially heterologous AIDS virus in rhesus monkeys by using an adjuvanted multicomponent protein vaccine J. Virol. 77 2003 1049 1058
8. S.A. Calarota, A. Kjerrstrom, K.B. Islam, and B. Wahren Gene combination raises broad human immunodeficiency virus-specific cytotoxicity Hum. Gene Ther. 12 2001 1623 1637
9. B. Wahren, and M. Liu Therapeutic vaccination against HIV Expert Rev. Vaccines 3 2004 S179 S188
10. M.G. Isaguliants, N.N. Petrakova, B. Zuber, K. Pokrovskaya, R. Gizatullin, D.A. Kostyuk, A. Kjerrstrom, G. Winberg, S.N. Kochetkov, J. Hinkula, and B. Wahren DNA-encoding enzymatically active HIV-1 reverse transcriptase, but not the inactive mutant, confers resistance to experimental HIV-1 challenge Intervirology 43 2000 288 293
11. G. Pantaleo, and R.A. Koup Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know Nat. Med. 10 2004 806 810
12. A.C. Leandersson, G. Gilljam, M. Fredriksson, J. Hinkula, A. Alaeus, K. Lidman, J. Albert, G. Bratt, E. Sandstrom, and B. Wahren Cross-reactive T-helper responses in patients infected with different subtypes of human immunodeficiency virus type 1 J. Virol. 74 2000 4888 4890
13. A. McMichael, M. Mwau, and T. Hanke HIV T cell vaccines, the importance of clades Vaccine 20 2002 1918 1921
14. T.M. Allen, and M. Altfeld HIV-1 superinfection J. Allergy Clin. Immunol. 112 2003 829 835
15. B. Wahren, K. Ljungberg, E. Rollman, M. Levi, B. Zuber, A. Kjerrstrom, J. Zuber, A.C. Hinkula, S. Leandersson, B. Calarota, G. Hejdeman, E. Bratt, and Sandstrom HIV subtypes and recombination strains-strategies for induction of immune responses in man Vaccine 20 2002 1988 1993
16. W.P. Kong, Y. Huang, Z.Y. Yang, B.K. Chakrabarti, Z. Moodie, and G.J. Nabel Immunogenicity of multiple gene and clade human immunodeficiency virus type 1 DNA vaccines J. Virol. 77 2003 12764 12772
17. J.B. Ulmer, J.J. Donnelly, S.E. Parker, G.H. Rhodes, P.L. Felgner, V.J. Dwarki, S.H. Gromkowski, R.R. Deck, C.M. DeWitt, A. Friedman, L.A. Hawe, R. Leander, D. Martinez, H.C. Perry, J.W. Shiver, D.L. Montgomery, and M.A. Liu Heterologous protection against influenza by injection of DNA encoding a viral protein Science 259 1993 1745 1749
18. K.E. Wang, V. Ugen, M.G. Srikantan, K. Agadjanyan, Y. Dang, A.I. Refaeli, J. Sato, W.V. Boyer, D.B. Williams, and Weiner Gene inoculation generates immune responses against human immunodeficiency virus type 1 Proc. Natl. Acad. Sci. USA 90 1993 4156 4160
19. M.A. Liu DNA vaccines: a review J. Intern. Med. 253 2003 402 410
20. M.J. Estcourt, A.J. McMichael, and T. Hanke DNA vaccines against human immunodeficiency virus type 1 Immunol Rev. 199 2004 144 155
21. E. Rollman, Concepts in DNA immunization: overcoming viral diversity and enhancing plasmid immunogenicity, Ph.D. thesis, http://diss.kib.ki.se/2004/91- 7349-943-9/, Karolinska Institute, Sweden, Stockholm, 2004.
22. S.A. Calarota, and D.B. Weiner Approaches for the design and evaluation of HIV-1 DNA vaccines Expert Rev. Vaccines 3 2004 S135 S149
23. J.O. Armitage Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor Blood 92 1998 4491 4508
24. H. Arteaga, Strategies of gene and immune therapy for tumors and viral diseases, Ph.D. thesis, ISBN:91-7349-528-X, http://diss.kib.ki.se/2003/91-7349- 528-x/, Karolinska Institute, Sweden, Stockholm, 2003.
25. D.H. Barouch, S. Santra, K. Tenner-Racz, P. Racz, M.J. Kuroda, J.E. Schmitz, S.S. Jackson, M.A. Lifton, D.C. Freed, H.C. Perry, M.E. Davies, J.W. Shiver, and N.L. Letvin Potent CD4+ T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSF J. Immunol. 168 2002 562 568
26. E. Rollman, J. Hinkula, J. Arteaga, B. Zuber, A. Kjerrstrom, M. Liu, B. Wahren, and K. Ljungberg Multi-subtype gp160 DNA immunization induces broadly neutralizing anti-HIV antibodies Gene Ther 11 2004 1146 1154
27. K. Ljungberg, E. Rollman, L. Eriksson, J. Hinkula, and B. Wahren Enhanced immune responses after DNA vaccination with combined envelope genes from different HIV-1 subtypes Virology 302 2002 44 57
28. S. Schwartz, M. Campbell, G. Nasioulas, J. Harrison, B.K. Felber, and G.N. Pavlakis Mutational inactivation of an inhibitory sequence in human immunodeficiency virus type 1 results in Rev-independent gag expression J. Virol. 66 1992 7176 7182
29. J. Hinkula, E. Rollman, P. Lundholm, R. Benthin, K. Okuda, and B. Wahren Genetic immunization with multiple HIV-1 genes provides protection against HIV-1/MuLV pseudovirus challenge in vivo Cells Tissues Organs 177 2004 169 184
30. A.K. Zuber, A. Brave, G. Engstrom, B. Zuber, K. Ljungberg, M. Fredriksson, R. Benthin, M.G. Isaguliants, E. Sandstrom, J. Hinkula, and B. Wahren Topical delivery of imiquimod to a mouse model as a novel adjuvant for human immunodeficiency virus (HIV) DNA Vaccine 22 2004 1791 1798
31. W. Seifarth, O. Frank, U. Zeilfelder, B. Spiess, A.D. Greenwood, R. Hehlmann, and C. Leib-Mosch Comprehensive analysis of human endogenous retrovirus transcriptional activity in human tissues with a retrovirus-specific microarray J. Virol. 79 2005 341 352
32. M.G. Isaguliants, S.O. Gudima, O.V. Ivanova, M. Levi, J. Hinkula, M.M. Garaev, S.N. Kochetkov, and B. Wahren Immunogenic properties of reverse transcriptase of HIV type 1 assessed by DNA and protein immunization of rabbits AIDS Res. Hum. Retroviruses 16 2000 1269 1280
33. S. Calarota, G. Bratt, S. Nordlund, J. Hinkula, A.C. Leandersson, E. Sandstrom, and B. Wahren Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients Lancet 351 1998 1320 1325
34. A. Kjerrström, J. Hinkula, G. Engstrom, V. Ovod, K. Krohn, R. Benthin, and B. Wahren Interactions of single and combined human immunodeficiency virus type 1 (HIV-1) DNA vaccines Virology 284 2001 46 61
35. B. Makitalo, P. Lundholm, J. Hinkula, C. Nilsson, K. Karlen, A. Morner, G. Sutter, V. Erfle, J.L. Heeney, B. Wahren, G. Biberfeld, and R. Thorstensson Enhanced cellular immunity and systemic control of SHIV infection by combined parenteral and mucosal administration of a DNA prime MVA boost vaccine regimen J. Gen. Virol. 85 2004 2407 2419
36. J.W. Yewdell, and J.R. Bennink Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses Ann. Rev. Immunol. 17 1999 51 88
37. A.L. Spetz, A.S. Sorensen, L. Walther-Jallow, B. Wahren, J. Andersson, L. Holmgren, and J. Hinkula Induction of HIV-1-specific immunity after vaccination with apoptotic HIV-1/murine leukemia virus-infected cells J. Immunol. 169 2002 5771 5779
38. M.S. Seaman, L. Xu, K. Beaudry, K.L. Martin, M.H. Beddall, A. Miura, A. Sambor, B.K. Chakrabarti, Y. Huang, R. Bailer, R.A. Koup, J.R. Mascola, G.J. Nabel, and N.L. Letvin multiclade human immunodeficiency virus type 1 envelope immunogens elicit broad cellular and humoral immunity in rhesus monkeys J. Virol. 79 2005 2956 2963
39. P. Lundholm, A.C. Leandersson, B. Christensson, G. Bratt, E. Sandstrom, and B. Wahren DNA mucosal HIV vaccine in humans Virus Res. 82 2002 141 145
40. K. Raviprakash, D. Ewing, M. Simmons, K.R. Porter, T.R. Jones, C.G. Hayes, R. Stout, and G.S. Murphy Needle-free Biojector injection of a dengue virus type 1 DNA vaccine with human immunostimulatory sequences and the GM-CSF gene increases immunogenicity and protection from virus challenge in Aotus monkeys Virology 315 2003 345 352
41. 5th FWP (Fifth Framework Programme), Study of immunogenicity of DNA HIV-1 env, gag and pol plasmid vaccines boosted with MVA in Tanzania: HIV vaccine immunogenicity study (http://dbs.cordis.lu/cordis-cgi/srchidadb?ACTION= D&SESSION=55422003-4-9&DOC=2&TBL=EN_PROJ&RCN=EP_RCN: 67520&CALLER=EN_UNIFIEDSRCH.%202003).
42. M. Bakari, E. Lyamuya, F. Mugusi, E. Aris, S. Chale, P. Magao, R. Jossiah, M. Janabi, A. Swai, N. Pallangyo, E. Sandstrom, F. Mhalu, G. Biberfeld, and K. Pallangyo The prevalence and incidence of HIV-1 infection and syphilis in a cohort of police officers in Dar es Salaam, Tanzania: a potential population for HIV vaccine trials AIDS 14 2000 313 320
43. M.P. Davenport, R.M. Ribeiro, D.L. Chao, and A.S. Perelson redicting the impact of a nonsterilizing vaccine against human immunodeficiency virus J. Virol. 78 2004 11340 11351